CORC

在结果中检索

CORC

浏览/检索结果: 共31条，第1-10条 帮助

限定条件                    
已选(0)清除 条数/页：   排序方式：
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor 期刊论文
THORACIC CANCER, 2022
作者:  Wang, Wenxian;  Wang, Qian;  Xu, Chunwei;  Li, Ziming;  Song, Zhengbo
收藏  |  浏览/下载：32/0  |  提交时间：2022/12/23
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文
THORACIC CANCER, 2022
作者:  Xu, Chunwei;  Si, Lu;  Wang, Wenxian;  Li, Ziming;  Song, Zhengbo
收藏  |  浏览/下载：36/0  |  提交时间：2022/12/22
A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17
作者:  Lu, S.;  Zhang, Y.;  Zhang, G.;  Zhou, J.;  Cang, S.
收藏  |  浏览/下载：23/0  |  提交时间：2022/12/23
Long-term exposure to copper induces mitochondria-mediated apoptosis in mouse hearts 期刊论文
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2022, 卷号: 234
作者:  Pan, Ming;  Zi-Wei Cheng;  Chen-Guang Huang;  Zhu-Qing Ye;  Li-Jun Sun
收藏  |  浏览/下载：133/0  |  提交时间：2022/05/16
Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements 期刊论文
NPJ PRECISION ONCOLOGY, 2022, 卷号: 6
作者:  Zhang, Yongchang;  Huang, Zhe;  Zeng, Liang;  Zhang, Xiangyu;  Li, Yizhi
收藏  |  浏览/下载：21/0  |  提交时间：2022/05/05
D-0316 in patients with advanced T790M-positive EGFR-mutant non-small cell lung cancer who progressed on prior EGFR-TKI therapy: results from a phase II study (NCT03861156). 期刊论文
CANCER RESEARCH, 2021, 卷号: 81
作者:  Lu, Shun;  Zhang, Yiping;  Zhang, Guojun;  Zhou, Jianying;  Cang, Shundong
收藏  |  浏览/下载：58/0  |  提交时间：2021/11/01
Chinese advanced fusion-dependent lung cancer patients: Molecular spectrum and treatment options using next generation sequencing-A multicenter study (Yangtze River Delta Lung Cancer Cooperation Group-001). 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Wang, Wen Xian;  Xu, Chun-Wei;  Li, Ziming;  Song, Zhengbo;  Fang, Wenfeng
收藏  |  浏览/下载：27/0  |  提交时间：2022/01/10
Safety and efficacy of apatinib as third or later line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma: A post-marketing phase IV study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Li, Jin;  Qin, Shukui;  Wen, Lu;  Wang, Junsheng;  Deng, Wenying
收藏  |  浏览/下载：24/0  |  提交时间：2022/01/10
Clinical effectiveness of apatinib at different doses in patients with advanced gastric cancer as the third-line or further treatment: Results from a post-marketing phase IV study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Li, Jin;  Qin, Shukui;  Wen, Lu;  Wang, Junsheng;  Deng, Wenying
收藏  |  浏览/下载：29/0  |  提交时间：2022/01/10
A Randomized Study Comparing Cisplatin/Paclitaxel Liposome vs Cisplatin/Gemcitabine in Chemonaive, Advanced Squamous NSCLC 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2021, 卷号: 16
作者:  Zhou, C.;  Jiang, L.;  Dong, X.;  Gu, K.;  Pan, Y.
收藏  |  浏览/下载：59/0  |  提交时间：2021/05/17

©版权所有 ©2017 CSpace - Powered by CSpace